Your search returned 144 studies. (Get alerts for new studies):
- Doxorubicin, Cyclophosphamide, and/or Paclitaxel in Treating Women With Nonmetastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving
Conditions: Breast Cancer - Neoplasm Metastasis
1 Location available
- Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
Conditions: Breast Cancer - Cognitive/Functional Effects - Lung Cancer - Metastatic Cancer - Prostate Cancer
41 Locations available
- Naltrexone in Treating Women With Metastatic Breast Cancer That Did Not Respond to Hormone Therapy
Conditions: Breast Cancer
1 Location available
- Spousal Relationships and Pain in Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Xenogeneic HER2/Neu DNA Immunization for Patients With Metastatic and High Risk Breast Cancer: A Phase I Study to Assess Safety and Immunogenicity
Conditions: Breast Cancer
1 Location available
- Phase II Gemzar, Taxol & Avastin Combination as 1st Line Tx for Metastatic Breast CA
Conditions: Breast Cancer - Breast Cancer Metastatic Breast Cancer
1 Location available
- A Phase II Study of Rapamycin and Trastuzumab for Patients With HER-2 Receptor Positive Metastatic Breast Cancer
Conditions: Breast Cancer
2 Locations available
- A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
Conditions: Metastatic Breast Cancer - Advanced Breast Cancer - Gastrointestinal Stromal Tumor - Hepatocellular Carcinoma - Metastasizing Breast Cancer (F) - Metastatic Castration-Resistant Prostrate Cancer - Metastatic Renal Cell Cancer - Non Small Cell Lung Cancer
2 Locations available
- Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients
Conditions: Breast Cancer
2 Locations available
- Bicalutamide in Treating Patients With Metastatic Breast Cancer
Conditions: Breast Cancer
8 Locations available
- Breast Imaging Using Indium In 111 CHX-A DTPA Trastuzumab in Patients With Primary Cancer or Metastatic Cancer
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer
Conditions: Breast Cancer
4 Locations available
- Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2
Conditions: Breast Cancer - Metastatic Cancer
1 Location available
- Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
Conditions: Breast Cancer - Colorectal Cancer - Gastric Cancer - Liver Cancer - Melanoma (Skin) - Metastatic Cancer - Ovarian Cancer - Pancreatic Cancer
1 Location available
- Study of Combined Fulvestrant and RAD001 in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure
Conditions: Breast Cancer
1 Location available
- Phase II Open-Label Trial of Tarceva in Women With Metastatic, Hormone- and HER2-Negative Breast Cancer
Conditions: Metastatic Breast Cancer
1 Location available
- Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
2 Locations available
- Sunitinib, Cyclophosphamide, and Methotrexate in Treating Patients With Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Irinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain Metastases
Conditions: Breast Cancer - Metastatic Cancer
1 Location available
- Sorafenib and Paclitaxel in Treating Patients With Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Phase II Study of Ixabepilone in Metastatic Breast Cancer and Its Effects on the Ultrastructure of Neurons
Conditions: Metastatic Breast Cancer
1 Location available
- Combination Chemotherapy Followed By Docetaxel or Ixabepilone in Treating Patients Who Have Undergone Surgery for Nonmetastatic Breast Cancer
Conditions: Breast Cancer
17 Locations available
- Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer
Conditions: Metastatic Breast Cancer
1 Location available
- AZD2281 and Carboplatin in Treating Patients With BRCA1/BRCA2-Associated, Hereditary, or Triple Negative Metastatic or Unresectable Breast Cancer or O
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Breast Cancer - Hereditary Breast/Ovarian Cancer (brca1, brca2) - Ovarian Cancer
1 Location available
- Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Conditions: Breast Cancer
6 Locations available
- Trial of 2nd Generation Anti-CEA Designer T Cells in Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-
Conditions: Metastatic Breast Cancer
28 Locations available
- A Phase I Cancer Vaccine Study for Patients With Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
1 Location available
- Pilot Study to Determine Radioiodide Accumulation and Dosimetry in Breast Cancers Using 124I PET/CT
Conditions: Breast Cancer - Breast Cancer Early Stage Breast Cancer (Stage 1-3) - Breast Cancer Metastatic Breast Cancer
1 Location available
- ABT-888 and Cyclophosphamide With Versus Without Doxorubicin in Treating Patients With Metastatic or Unresectable Solid Tumors or Non-Hodgkin Lymphoma
Conditions: Breast Cancer - Lymphoma - Lymphoproliferative Disorder - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- A Phase I/II Clinical Trial of Vidaza With Abraxane in the Treatment of Patients With Advanced or Metastatic Solid Tumors and Breast Cancer
Conditions: Advanced or Metastatic Solid Tumors - Advanced or Metastatic Breast Cancer
1 Location available
- Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer
Conditions: Breast Cancer - Chemotherapeutic Agent Toxicity - Palmar-Plantar Erythrodysesthesia
1 Location available
- Lapatinib in Women With Metastatic Breast Cancer Who Have Failed Prior Antihormone Therapy
Conditions: Metastatic Breast Cancer
3 Locations available
- Personalized Treatment Selection for Dasatinib in Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Vaccine Therapy and Aldesleukin in Treating Women With Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Dasatinib and Bevacizumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot be Removed by Surgery
Conditions: Breast Cancer - Gastrointestinal Stromal Tumor - Intraocular Melanoma - Kidney Cancer - Lung Cancer - Melanoma (Skin) - Ovarian Cancer - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Chemotherapeutic Agents in Brain/Breast
Conditions: Breast Cancer - Metastatic Cancer
2 Locations available
- Mammaglobin-A DNA Vaccine for Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
1 Location available
- Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Conditions: Breast Cancer - Breast Neoplasms - Breast Tumors - Cancer - Locally Recurrent and Metastatic Breast Cancer - Metastases - Metastatic Cancer - Oncology - Solid Tumors - Tumors
5 Locations available
- Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194
Conditions: Breast Cancer
1 Location available
- Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer.
Conditions: Metastatic Breast Cancer - Metastases, Brain
1 Location available
- Agatolimod and Trastuzumab in Treating Patients With Locally Advanced or Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
14 Locations available
- Trial of RAD001 in Triple Negative Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Gene Therapy in Treating Women With Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer: Concordance Study
Conditions: Breast Cancer
1 Location available
- Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma and Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
440 Locations available
- Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
12 Locations available
- Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Conditions: Breast Cancer - Hypercalcemia of Malignancy - Colon Cancer - Endocrine Cancer - Head and Neck Cancer - Kidney Cancer - Lung Cancer - Lymphoma - Metastatic Cancer - Multiple Myeloma - Parathyroid Neoplasms - Renal Cancer - Thyroid Cancer - Hodgkin's Lympho
9 Locations available
- Identifying Circulating Breast Cancer Cells in Women With Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- DNA Analysis of Tumor Tissue Samples From Patients With Recurrent or Metastatic Breast Cancer That Expresses HER2
Conditions: Breast Cancer
1 Location available
- Randomized Phase II Trial of Trastuzumab or EVEROLIMUS in Hormone-refractory Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
13 Locations available
- Trastuzumab and Trastuzumab-MCC-DM1 Administered Intravenously and GDC-0941 Administered Orally to Patients With HER2-Positive Metastatic Breast Cance
Conditions: Metastatic Breast Cancer
3 Locations available
- Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast Ca
Conditions: Breast Cancer
1 Location available
- A Study of NK012 in Patients With Advanced, Metastatic Triple Negative Breast Cancer
Conditions: Triple Negative Breast Cancer
1 Location available
- A Study of Trastuzumab-MCC-DM1, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced or Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
4 Locations available
- A Study of PI3-Kinase Inhibitor GDC-0941 in Combination With Paclitaxel and Bevacizumab in Patients With Locally Recurrent or Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer, Locally Recurrent Breast Cancer
1 Location available
- 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors
Conditions: Kidney Cancer - Head and Neck Cancer - Breast Cancer - Non-small Cell Lung Cancer - Colorectal Cancer - Pancreatic Cancer - Ovarian Cancer - Esophageal Cancer - Gliomas
1 Location available
- Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone
Conditions: Adenocarcinoma - Her2+ - Advanced Metastatic Breast Cancer - Metastatic ErbB2 - Invasive Breast Cancer - Advanced Breast Cancer - Cancer - ErbB2+
19 Locations available
- Cyclophosphamide and Vaccine Therapy With or Without Trastuzumab in Treating Patients With Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Cyclosporine A in Combination With Nab-Paclitaxel in Patients With Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
1 Location available
- High-Dose Methotrexate and Liposomal Cytarabine in Treating Patients With Central Nervous System (CNS) Metastases From Breast Cancer
Conditions: Stage IV Breast Cancer - Central Nervous System Involvement/Metastases - Leptomeningeal Metastases - Recurrent Breast Cancer - Tumors Metastatic to Brain
1 Location available
- A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Conditions: ErbB2 Overexpressing - Solid Tumors - Metastatic Breast Cancer - Neoplasms, Breast
8 Locations available
- Tissue Repository for Correlation of Molecular Markers With Response to Neoadjuvant and Metastatic Chemotherapy
Conditions: Breast Cancer
2 Locations available
- Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer
Conditions: HER2/Neu Over-expressing Locally Advanced Breast Cancer - Metastatic Breast Cancer
37 Locations available
- Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast Cancer
Conditions: Breast Cancer - Recurrent Breast Cancer - Stage IV Breast Cancer
2 Locations available
- Laboratory-Treated T Cells After Second-Line Chemotherapy in Treating Women With HER2/Neu-Negative Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Trial of Amrubicin as Treatment for Patients With HER2-Negative Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
13 Locations available
- Study of Ad.p53 DC Vaccine and 1-MTin Metastatic Invasive Breast Cancer
Conditions: Breast Cancer
1 Location available
- MLN8237 in Adults With Nonhematological Malignancies, Followed by MLN8237 in Lung, Breast, Head and Neck or Gastroesophageal Malignancies
Conditions: Advanced Nonhematological Malignancies - Non-Small Cell Lung Cancer - Small Cell Lung Cancer - Metastatic Breast Cancer - Head and Neck Squamous Cell Carcinoma - Gastroesophageal Adenocarcinoma
3 Locations available
- Use of PRO Onc Assay to Assess HER2 in Patients With Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Characterization of Circulating Tumor Cells (CTCs) to Direct Pre-Operative and Systemic Therapy in Patients With Locally Advanced or Metastatic Stage
Conditions: Locally Advanced Breast Cancer - Metastatic (Stage IV) Breast Cancer - Stage III-IV Breast Cancer or Inflammatory
1 Location available
- Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Non-Metastatic, Post Menopausal Breast Cancer Patients
Conditions: Breast Cancer
1 Location available
- Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer
Conditions: Metastatic Non Small Cell Lung Cancer - Metastatic Breast Cancer
1 Location available
- Pilot Study Using Molecular Profiling to Find Potential Targets and Select Treatments for Patients With Metastatic Breast Cancer.
Conditions: Metastatic Breast Cancer
3 Locations available
- Ixabepilone and Vorinostat in Treating Patients With Metastatic Breast Cancer
Conditions: Male Breast Cancer - Recurrent Breast Cancer - Stage IV Breast Cancer
2 Locations available
- MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer
Conditions: HER2 Amplified Breast Cancer - Metastatic or Advanced Breast Cancer
3 Locations available
- Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Hereditary Breast/Ovarian Cancer - BRCA1 - Hereditary Breast/Ovarian Cancer - BRCA2 - Male Breast Cancer - Progesterone Receptor-negative Breast Cancer - Recurrent Breast Cancer - Stage IIIC Breast Cancer - Stage
1 Location available
- Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Conditions: Breast Cancer
91 Locations available
- Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Cancer - Breast Cancer
1 Location available
- Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer
Conditions: Breast Cancer
5 Locations available
- Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
4 Locations available
- A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Patients With Metastatic B
Conditions: Breast Cancer
6 Locations available
- Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Conditions: Breast Cancer
253 Locations available
- LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Conditions: Breast Neoplasms
38 Locations available
- Safety and Efficacy of BKM120 in Combination With Trastuzumab in Patients With Relapsing HER2 Overexpressing Breast Cancer Who Have Previously Failed
Conditions: Metastatic Breast Cancer - Trastuzumab - BKM120 - HER2+
13 Locations available
- Fulvestrant With or Without Bortezomib in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Conditions: Breast Cancer
8 Locations available
- RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cancer
Conditions: Breast Cancer
4 Locations available
- Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Pos
Conditions: Her2 Negative Breast Cancer Patients
21 Locations available
- Study Evaluating the Safety and Efficacy of Onartuzumab (Metmab) And/Or Bevacizumab in Combination With Paclitaxel in Patients With Metastatic, Triple
Conditions: Breast Cancer
17 Locations available
- Safety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast Cancer
Conditions: Advanced or Metastatic Breast Cancer
5 Locations available
- A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers
Conditions: Locally Advanced/Metastatic or Recurrent Ovarian Cancer, Fallopian Tube Cancer, - Primary Peritoneal Cancer or Endometrial Cancer - Locally Advanced/Metastatic Her2 Non Overexpressing Breast Cancer
3 Locations available
- Tesetaxel as First-line Therapy for Metastatic Breast Cancer
Conditions: Breast Neoplasm
2 Locations available
- Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
5 Locations available
- Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breas
Conditions: Breast Cancer
11 Locations available
- PhIb BKM120 or BEZ235+Endocrine Treatment in Post-Menopausal Patients With Hormone Receptor + Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
3 Locations available
- Vorinostat in Combination With Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
Conditions: Anal Cancer - Breast Cancer - Esophageal Cancer - Gastric Cancer - Head and Neck Cancer - Lung Cancer - Nonneoplastic Condition - Ovarian Cancer - Unspecified Adult Solid Tumor, Protocol Specific
6 Locations available
- Veliparib and Carboplatin in Treating Women With HER2-Negative Metastatic Breast Cancer
Conditions: Breast Cancer
3 Locations available
- Safety and Efficacy of INCB007839 With Trastuzumab and Vinorelbine in Patients With Metastatic HER2+ Breast Cancer
Conditions: Breast Cancer
3 Locations available
- TKI258 for Metastatic Inflammatory Breast Cancer Patients
Conditions: Breast Cancer
1 Location available
- MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer
Conditions: Breast Cancer - Unspecified Adult Solid Tumor, Protocol Specific
3 Locations available
- A Study of Single-Agent Eribulin Mesylate as First-Line Therapy for Locally Recurrent or Metastatic Human Epidermal Growth Factor Receptor Two (HER2)
Conditions: Locally Recurrent or Metatastic Breast Cancer ( HER2 Negative)
15 Locations available
- Eribulin With Trastuzumab as First-line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer
Conditions: Breast Cancer
7 Locations available
- Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Metastatic Breast Cancer
Conditions: Breast Neoplasms - HER2 Protein, Human - Geriatric Health Services
3 Locations available
- Paclitaxel, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer
Conditions: Breast Cancer
5 Locations available
- Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Conditions: Breast Cancer - Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- Lapatinib Ditosylate and MK2206 in Treating Women With Metastatic Breast Cancer
Conditions: Breast Cancer
3 Locations available
- Lapatinib and RAD-001 for HER2 Positive Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
1 Location available
- Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer
Conditions: HER2-negative Breast Cancer - Male Breast Cancer - Recurrent Breast Cancer - Stage IIIC Breast Cancer - Stage IV Breast Cancer
1 Location available
- Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast Cancer
Conditions: Breast Cancer
2 Locations available
- Study of BKM120 or BEZ235 and Capecitabine in Patients With Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
2 Locations available
- A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid Tumors
Conditions: Advanced Solid Tumors - Locally Advanced or Metastatic Breast or Colorectal Cancer
3 Locations available
- Open Label Dose-Finding Study of TRC105 Plus Capecitabine for Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
1 Location available
- Z-Endoxifen Hydrochloride in Treating Patients With Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast Cancer
Conditions: Breast Cancer - Hot Flashes
1 Location available
- A Clinical Trial Comparing Gemcitabine and Carboplatin With and Without P276-00 in Subjects With Metastatic Triple Negative Breast Cancer, With a Run-
Conditions: Breast Cancer
4 Locations available
- Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Br
Conditions: Castration-resistant Prostate Cancer, - Metastatic Breast Cancer
4 Locations available
- MK2206 and Anastrozole, Letrozole, Exemestane, or Fulvestrant in Treating Postmenopausal Women With Metastatic Breast Cancer
Conditions: Breast Cancer
3 Locations available
- Radioactive Iodide (131I) Treatment of 124I PET/CT Detected Breast Cancers
Conditions: Breast Cancer - Metastatic Breast Cancer
1 Location available
- AUY922 With Lapatinib and Letrozole for ER+ HER2+ Advanced Breast Cancer
Conditions: Breast Cancer - Metastatic Breast Cancer - HER-2 Positive Breast Cancer - ER Positive Breast Cancer
1 Location available
- Vaccine Therapy in Treating Patients With Metastatic Solid Tumors
Conditions: Malignant Solid Tumour - Breast Cancer - Malignant Tumor of Colon - GIST - Ovarian Cancer
1 Location available
- A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Bre
Conditions: Metastatic ER+ Her2- Breast Cancer - Postmenopausal
14 Locations available
- Therapeutic Estradiol and Exemestane in Treating Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer
Conditions: Estrogen Receptor-positive Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IIIC Breast Cancer - Stage IV Breast Cancer
1 Location available
- Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Conditions: Locally Advanced Solid Tumor - Metastatic Solid Tumor - Breast Cancer - Non Small Cell Lung Cancer - Melanoma - Colorectal Cancer
2 Locations available
- Fresolimumab and Radiotherapy in Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
1 Location available
- Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy
Conditions: Metastatic Breast Cancer
16 Locations available
- A Study of LY2523355 in Patients With Breast Cancer
Conditions: Metastatic Breast Cancer
7 Locations available
- Toll-like Receptor (TLR) 7 Agonist and Radiotherapy for Breast Cancer With Skin Metastases
Conditions: Breast Cancer - Metastatic Breast Cancer - Recurrent Breast Cancer
1 Location available
- Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer
Conditions: Breast Cancer
4 Locations available
- Entinostat and Lapatinib Ditosylate in Patients With Locally Recurrent or Distant Relapsed Metastatic Breast Cancer Previously Treated With Trastuzuma
Conditions: Breast Cancer
1 Location available
- Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in Patients Resistant to Aromatase Inhibitor
Conditions: Breast Cancer
6 Locations available
- Cabozantinib in Women With Metastatic Hormone-Receptor-Positive Breast Cancer
Conditions: Breast Cancer
3 Locations available
- Efficacy and Safety of Chloroquine in Combination With Taxane or Taxane-like Chemotherapy in the Treatment of Advanced or Metastatic Breast Cancer Pat
Conditions: Breast Neoplasms - Breast Cancer
1 Location available
- Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer
Conditions: Hormone-sensitive, HER-2 Negative Metastatic Breast Cancer
11 Locations available
- Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumors - Metastatic Breast Cancer - Metastatic Renal Cell Carcinoma
1 Location available
- A Study of Oral Rucaparib in Patients With gBRCA Mutation Breast or Ovarian Cancer, or Other Solid Tumor
Conditions: Metastatic Solid Tumor - Breast Cancer - Ovarian Cancer
2 Locations available
- A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Patients With Hormone Receptor-Positive, Metastatic HER2-positive
Conditions: Breast Cancer
2 Locations available
- The BEACON Study (Breast Cancer Outcomes With NKTR-102)
Conditions: Locally Recurrent Breast Cancer - Metastatic Breast Cancer
60 Locations available
- The Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide or In Combination With Carboplatin and Paclitaxel Versus
Conditions: Metastatic Breast Cancer
3 Locations available
- Tivantinib in Treating Patients With Recurrent or Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects
Conditions: Metastatic Breast Cancer
4 Locations available
|